RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
about
RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
RE: RNA Disruption Assay as a ...... ptor 2-Positive Breast Cancer.
@en
RE: RNA Disruption Assay as a ...... ptor 2-Positive Breast Cancer.
@nl
type
label
RE: RNA Disruption Assay as a ...... ptor 2-Positive Breast Cancer.
@en
RE: RNA Disruption Assay as a ...... ptor 2-Positive Breast Cancer.
@nl
prefLabel
RE: RNA Disruption Assay as a ...... ptor 2-Positive Breast Cancer.
@en
RE: RNA Disruption Assay as a ...... ptor 2-Positive Breast Cancer.
@nl
P2093
P2860
P50
P356
P1476
RE: RNA Disruption Assay as a ...... ptor 2-Positive Breast Cancer.
@en
P2093
Anthony O'Grady
Bryan T Hennessy
Elaine W Kay
John Crown
John Kennedy
Ken P H Pritzker
Laura B Pritzker
Liam Grogan
Norma O'Donovan
Robert Cummins
P2860
P356
10.1093/JNCI/DJW111
P407
P577
2016-07-04T00:00:00Z